Sarclisa and Renal impairment - a phase IV clinical study of FDA data
Renal impairment is found among people who take Sarclisa, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Sarclisa and have Renal impairment. It is created by eHealthMe based on reports of 236 people who have side effects when taking Sarclisa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
236 people reported to have side effects when taking Sarclisa.
Among them, 6 people (2.54%) have Renal impairment.
What is Sarclisa?
Sarclisa has active ingredients of isatuximab-irfc. eHealthMe is studying from 237 Sarclisa users for its effectiveness, alternative drugs and more.
What is Renal impairment?
Renal impairment (severely reduced kidney function) is found to be associated with 2,619 drugs and 2,332 conditions by eHealthMe.
Number of Sarclisa and Renal impairment reports submitted per year:
Time on Sarclisa when people have Renal impairment *:
Gender of people who have Renal impairment when taking Sarclisa*:
Age of people who have Renal impairment when taking Sarclisa *:
Common drugs people take besides Sarclisa *:
Common side effects people have besides Renal impairment *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Sarclisa and have Renal impairment?Check whether Renal impairment is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
How severe was Renal impairment and when was it recovered:
Expand to all the drugs that have ingredients of isatuximab-irfc:
Alternative drugs to, pros and cons of Sarclisa:
- Sarclisa (237 reports)
Renal impairment treatments and more:
- Renal impairment (85,016 reports)
COVID vaccines that are related to Renal impairment:
- Renal impairment in Moderna COVID Vaccine
- Renal impairment in Pfizer BioNTech Covid Vaccine
- Renal impairment in Johnson and Johnson Covid Vaccine
Common drugs associated with Renal impairment:
All the drugs that are associated with Renal impairment:
- Renal impairment (2,619 drugs)
Common conditions associated with Renal impairment:
All the conditions that are associated with Renal impairment:
- Renal impairment (2,332 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on isatuximab-irfc (the active ingredients of Sarclisa) and Sarclisa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Systemic Lupus Erythematosus and Migraine - 2 seconds ago
- Cholestyramine Light and Ibuprofen drug interaction - 3 seconds ago
- Nuclear Magnetic Resonance Imaging Abdominal and Breathing Difficulty - 5 seconds ago
- Calcium Gluconate and Sinemet drug interaction - 8 seconds ago
- Hair Loss and Hyponatremia - 9 seconds ago
- Vitamin E and Histamine Level Increased - 29 seconds ago
- Lovenox and Hydrodiuril drug interaction - 29 seconds ago
- Desowen and Diabetes - 30 seconds ago
- Lamictal vs. Depakote - 31 seconds ago
- Pleurisy and Thrombocytopenia - 49 seconds ago